PerioC Limited Report issue

For profit Phase 2
Founded: Ongar United Kingdom (2012)
Status: Defunct (2017)

Organization Overview

First Clinical Trial
2015
NCT02366585
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

cyclosporine (sandimmune) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Periodontal Pocket (Phase 2)

Periodontitis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1